The Journal of Bone and Joint Surgery (American). 2007;89:255-260.
doi:10.2106/JBJS.F.00401
© 2007 The Journal of Bone and Joint Surgery, Inc.
Treatment of Chronic Radial Epicondylitis with Botulinum Toxin A
A Double-Blind, Placebo-Controlled, Randomized Multicenter Study
Richard Placzek, MD1,
Wolf Drescher, MD, PhD2,
Georg Deuretzbacher, PhD3,
Axel Hempfing, MD4 and
A. Ludwig Meiss, MD3
1 Centrum für Muskuloskeletale Chirurgie, Kliniken für
Orthopädie, Unfall- und Wiederherstellungschirurgie, Campus
Virchow-Klinikum, Charité-Universitätsmedizin Berlin,
Augustenburger Platz 1, 13353 Berlin, Germany. E-mail address:
richard.placzek{at}charite.de
2 Orthopädische Universitätsklinik Frankfurt a.M. Marienburgstrasse 2,
60528 Frankfurt am Main, Germany
3 Orthopädische Universitätsklinik Hamburg-Eppendorf Martinistrasse
52, 20246 Hamburg, Germany
4 Orthopädische Universitätsklinik Heidelberg, Schlierbacher
Landstrasse 200a, 69118 Heidelberg, Germany
Investigation performed at Orthopädische Universitätsklinik
Hamburg-Eppendorf, Hamburg, Germany
Disclosure: In support of their research for or preparation of this
work, one or more of the authors received, in any one year, outside funding or
grants in excess of $10,000 from Ipsen Pharma, Ettlingen, Germany. Neither
they nor a member of their immediate families received payments or other
benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, division, center,
clinical practice, or other charitable or nonprofit organization with which
the authors, or a member of their immediate families, are affiliated or
associated.
Background: Radial epicondylitis (tennis elbow) is the most frequent
type of myotendinosis. Patients can experience substantial loss of function,
especially when this condition becomes chronic. A successful therapy has not
yet been established. A preliminary study of injections of botulinum toxin A
in patients with chronic epicondylitis has shown promising results.
Methods: In the present prospective, controlled, double-blinded
clinical trial, 130 patients were examined at sixteen study centers. A single
injection of botulinum toxin A into the painful origin of the forearm extensor
muscles was performed. Follow-up examinations were performed at two, six,
twelve, and eighteen weeks. Clinical findings were documented with use of a
new clinical pain score and with a visual analogue scale. A global assessment
of the result of treatment was also provided by the patient and the attending
doctor. Strength of extension of the third finger and the wrist was evaluated
with use of the Brunner method, and grip strength (fist closure strength) was
measured with a vigorimeter.
Results: The group treated with botulinum toxin A was found to have
a significant improvement in the clinical findings, compared with those in the
placebo group, as early as the second week after injection (p = 0.003).
Subjective general assessment also showed improvement in that group, compared
with the placebo group, at six weeks (p = 0.001) and at the time of the final
examination (at eighteen weeks) (p = 0.001). There was a consistent increase
in fist closure strength in both the group treated with botulinum toxin A and
the control group, but there was no significant difference between groups. As
was expected as a side effect, extension of the third finger was observed to
be significantly weakened at two weeks but this complication had completely
resolved at eighteen weeks.
Conclusions: We concluded that local injection of botulinum toxin A
is a beneficial treatment for radial epicondylitis (tennis elbow). The
treatment can be performed in an outpatient setting and does not impair the
patient's ability to work.
Level of Evidence: Therapeutic Level I. See Instructions
to Authors for a complete description of levels of evidence.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Meknas, A. Odden-Miland, J. B. Mercer, M. Castillejo, and O. Johansen
Radiofrequency Microtenotomy: A Promising Method for Treatment of Recalcitrant Lateral Epicondylitis
Am. J. Sports Med.,
October 1, 2008;
36(10):
1960 - 1965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Zeisig, M Fahlstrom, L Ohberg, and H Alfredson
Pain relief after intratendinous injections in patients with tennis elbow: results of a randomised study
Br. J. Sports Med.,
April 1, 2008;
42(4):
267 - 271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Ramsey, C. L. Getz, and B. O. Parsons
What's New in Shoulder and Elbow Surgery
J. Bone Joint Surg. Am.,
March 1, 2008;
90(3):
677 - 687.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. De Smedt, A. de Jong, W. Van Leemput, D. Lieven, and F. Van Glabbeek
Lateral epicondylitis in tennis: update on aetiology, biomechanics and treatment
Br. J. Sports Med.,
November 1, 2007;
41(11):
816 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Letters to the Editor:
Read all Letters to the Editor
- Treatment of chronic radial epicondylitis with botulinum toxin A: A novel molecular mechanism.
- Hamid Namazi, M.D.
- JBJS Online, 11 Mar 2008
[Full text]
- Dr. Placzek et al. respond to Dr. Namazi
- Richard Placzek, M.D., et al.
- JBJS Online, 27 Mar 2008
[Full text]
|